第 10 節 抗微生物劑
Antimicrobial agents
- 10.1抗微生物劑用藥給付規定通則
- 10.2盤尼西林類 Penicillins
- 10.3頭孢子菌素 Cephalosporins
- 10.4巨環類Macrolides如 erythromycin、azithromycin、clarithromycin、roxithromycin111/3/1
- 10.5Carbapenem類抗微生物製劑
- 10.6抗黴菌劑 Antifungal drugs
- 10.6.1Fluconazole
- 10.6.2刪除108/12/1
- 10.6.3Itraconazole98/8/1
- 10.6.4Terbinafine如 Lamisil tab98/8/1
- 10.6.5Amphotericin B Injection colloidal dispersion及liposomal complex劑型如 Amphocil Injection、AmBisome for Injection93/2/1
- 10.6.6Caspofungin Injection劑型如 Cancidas Injection 50mg99/10/1
- 10.6.7Micafungin Injection劑型如 Mycamine for Injection111/2/1
- 10.6.8Flucytosine如 Flusine Tablets96/6/1
- 10.6.9Anidulafungin注射劑如 Eraxis for Injection111/5/1
- 10.6.10Posaconazole如 Posanol111/2/1
- 10.6.11Isavuconazole如 Cresemba110/2/1
- 10.7抗病毒劑 Antiviral drugs98/11/1
- 10.7.1抗疱疹病毒劑98/11/1
- 10.7.2Ribavirin 膠囊劑如 Robatrol、Rebetol114/6/1
- 10.7.3Lamivudine 100mg如 Zeffix、Baraclude、Sebivo、Viread、Vemlidy114/6/1
- 10.7.4Adefovir dipivoxil如 Hepsera Tablets 10mg、Baraclude 1.0mg、Viread、Vemlidy111/9/1
- 10.7.5Daclatasvir如 Daklinza、Sunvepra109/1/1
- 10.7.6Ombitasvir/paritaprevir/ ritonavir如 Viekirax、Exviera110/6/1
- 10.7.7Elbasvir/grazoprevir如 Zepatier110/6/1
- 10.7.8Sofosbuvir/ledipasvir如 Harvoni114/12/1
- 10.7.9Sofosbuvir如 Sovaldi109/7/1
- 10.7.10Glecaprevir/pibrentasvir如 Maviret114/12/1
- 10.7.11Sofosbuvir/velpatasvir如 Epclusa114/12/1
- 10.7.12Letermovir如 Prevymis109/6/1
- 10.7.13Sofosbuvir/ velpatasvir/ voxilaprevir如 Vosevi114/12/1
- 10.7.14Maribavir如 Livtencity113/11/1
- 10.8其他 Miscellaneous
- 10.8.1Teicoplanin及vancomycin110/7/1
- 10.8.2Quinolone類108/12/1
- 10.8.3Linezolid如 Zyvox Injection及Tablets108/4/1
- 10.8.4(本項刪除)。
- 10.8.5Tigecycline如 Tygacil100/7/1
- 10.8.6Colistin可用於靜脈注射劑99/2/1
- 10.8.7Daptomycin注射劑98/1/1
- 10.8.8Fidaxomicin如 Dificid103/9/1
- 10.8.9Minocycline注射劑114/1/1
- 10.8.10Polymyxin B sulfate靜脈注射劑113/12/1
- 10.9抗人類免疫缺乏病毒藥品使用規定106/2/4
